All In MedTech

Device Trial Radar · NCT06285695

Clareon Toric Study (T2-T9)

Clareon Toric Single Arm Study (T2-T9)

Last checked: Nov 20, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

129

Actual

Start

Apr 10, 2024

Primary completion

Jun 25, 2026

Study completion Jun 25, 2026

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Feb 29, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post-market study is to describe the long-term safety and performance of Clareon Toric Intraocular Lenses (IOLs).

Conditions

  • Aphakia
  • Corneal Astigmatism

Interventions

  • Clareon Toric IOLDevice

    Aspheric hydrophobic acrylic IOL placed in the capsular bag in the posterior chamber of the eye during cataract surgery for the visual correction of aphakia and preexisting corneal astigmatism

  • Cataract surgeryProcedure

    Cataract extraction by phacoemulsification, followed by implantation with a Clareon Toric IOL

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean monocular best corrected distance visual acuity (BCDVA)Time frame: Month 6, Year 1

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Gimbel Eye Centre

    Calgary, Alberta, Canada

  • Uptown Eye Specialists

    Concord, Ontario, Canada

  • Prism Eye Institute

    Oakville, Ontario, Canada

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.